Open AccessDelayed hemodialysis in COVID-19: Case series with literature review
Author(s) -
Michael Connerney,
Yasar Sattar,
Hiba Rauf,
Sahil Mamtani,
Waqas Ullah,
Nara Miriam Michaelson,
Umaima Dhamrah,
Naman Lal,
Sharaad Latchana,
Aaron Stern
Publication year - 2021
Publication title -
clinical nephrology - case studies
Language(s) - English
Resource type - Journals
ISSN - 2196-5293
DOI - 10.5414/cncs110240
Subject(s) - covid-19 , hemodialysis , series (stratigraphy) , medicine , intensive care medicine , virology , biology , outbreak , disease , paleontology , infectious disease (medical specialty)
Increased incidence of kidney injury has been seen in patients with COVID-19. However, less is known about COVID-19 susceptibility and outcomes in end-stage renal disease (ESRD) patients on hemodialysis (HD). Reduced angiotensin-converting enzyme 2 (ACE-2) from SARS-CoV-2 binding and increased angiotensin II (Ang-II) activity have been suggested as mechanisms for COVID-19 renal pathophysiology.